NASDAQ:KTOV Purple Biotech (KTOV) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free KTOV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.45▼$0.5950-Day Range$3.81▼$4.9452-Week Range$2.20▼$14.40Volume266,544 shsAverage Volume1.18 million shsMarket Capitalization$8.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get Purple Biotech alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About Purple Biotech Stock (NASDAQ:KTOV)Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension in the United States, as well as in China and South Korea. Its oncology pipeline includes NT-219, a small molecule that is advancing as a monotherapy treatment of advanced solid tumors and in combination with cetuximab for the treatment of recurrent or metastatic squamous cell carcinoma of head and neck cancer in a planned phase 1/2 study; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD1 checkpoint inhibitors for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. is headquartered in Tel Aviv, Israel.Read More Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. KTOV Stock News HeadlinesMarch 6, 2024 | markets.businessinsider.comPromising Pipeline Prospects for Purple Biotech: Buy Rating Affirmed Amidst Anticipated Clinical AdvancementsNovember 21, 2023 | benzinga.comPurple Biotech: Q3 Earnings InsightsApril 25, 2024 | The TradingPub (Ad)At first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”November 21, 2023 | msn.comPurple Biotech GAAP EPS of -$0.23October 30, 2023 | msn.comPurple Biotech files to sell 4.65M ADS for holdersAugust 25, 2023 | benzinga.comAlukovinyl Provides Customised And Innovative Purple Car Wrap Films For Car Owners WorldwideAugust 24, 2023 | benzinga.comPurple Biotech Stock (NASDAQ:PPBT), Earnings Estimates, EPS, and RevenueAugust 22, 2023 | benzinga.comPurple Biotech Reports Second Quarter 2023 Financial ResultsApril 25, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… July 19, 2023 | seekingalpha.comPPBT Purple Biotech Ltd.July 9, 2023 | latimes.comPurple Carrot Discount CodesJune 29, 2023 | reuters.comPurple Promo Codes 2023May 17, 2023 | markets.businessinsider.comPurple Biotech (PPBT) Receives a Buy from H.C. WainwrightMarch 24, 2023 | seekingalpha.comPurple Biotech CEO Gil Efron takes medical leave, Isaac Israel named acting CEOSeptember 9, 2022 | finance.yahoo.comRapidly Growing Purple Brands Announces New Director of WinemakingAugust 12, 2022 | finance.yahoo.com‘Purple Hearts’ Star Sofia Carson and Director Elizabeth Allen Rosenbaum Defend Netflix Film After Backlash: ‘Our Intentions Are Very Pure’July 14, 2022 | marketwatch.comPurple Biotech Names Efron CEO as Israel Steps Down >PPBTJune 2, 2022 | yahoo.comBiotech company says woman received 3D printed ear made from her own cellsMay 12, 2022 | finance.yahoo.comPurple Biotech Reports First Quarter 2022 Financial ResultsSee More Headlines Receive KTOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:KTOV CUSIPN/A CIK1614744 Webwww.kitovpharma.com Phone972-3933-3121FaxN/AEmployees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio2.22 Quick RatioN/A Sales & Book Value Annual Sales$1 million Price / Sales7.71 Cash FlowN/A Price / Cash FlowN/A Book Value$5.56 per share Price / Book0.09Miscellaneous Outstanding Shares15,725,000Free FloatN/AMarket Cap$7.71 million OptionableNot Optionable Beta2.37 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Isaac Israel (Age 42)CEO & Director Comp: $564.48kMr. Gil Efron CPA (Age 54)Deputy CEO & CFO Comp: $356.91kMr. Avraham Shlomo Ben-Tzvi (Age 49)Group Chief Legal Officer, Gen. Counsel & Corp. Sec. Mr. Simcha Rock CPA (Age 70)M.B.A., CPA, MBA, Strategic Advisor & Director Dr. Bertrand C. Liang (Age 57)Chief Medical Officer Dr. Michael Schickler (Age 62)Head of Clinical Operations More ExecutivesKey CompetitorsLixte BiotechnologyNASDAQ:LIXTASLAN PharmaceuticalsNASDAQ:ASLNBiofronteraNASDAQ:BFRITFF PharmaceuticalsNASDAQ:TFFPBionomicsNASDAQ:BNOXView All Competitors KTOV Stock Analysis - Frequently Asked Questions When did Purple Biotech's stock split? Purple Biotech shares reverse split on the morning of Saturday, August 22nd 2020. The 1-10 reverse split was announced on Friday, August 21st 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 21st 2020. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Purple Biotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Purple Biotech investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), T2 Biosystems (TTOO), Southwestern Energy (SWN), VBI Vaccines (VBIV), Onconova Therapeutics (ONTX), Advanced Micro Devices (AMD), Vaxart (VXRT), Amarin (AMRN) and Citius Pharmaceuticals (CTXR). When did Purple Biotech IPO? Purple Biotech (KTOV) raised $13 million in an initial public offering on Friday, November 20th 2015. The company issued 3,200,000 shares at $4.13 per share. Rodman & Renshaw (a unit of H.C. Wainwright & Co.,) and Joseph Gunnar acted as the underwriters for the IPO. This page (NASDAQ:KTOV) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
